Biosimilar medicines in community pharmacy
The expanding use of biosimilar medicines in Australia is expected to deliver significant savings, which can be reinvested back into the Australian healthcare system.
This session will focus on biosimilar medicine use in a community pharmacy setting and examine topics including what are biosimilars, the pharmacist’s role in the uptake of biosimilars in Australia and the importance of patient choice.
The session will also explore how pharmacists can utilise the suite of resources made available by the Department of Health and GBMA Education.
When: 12.05 pm – 12.50 pm, Friday 6 September
Proudly sponsored by: